Literature DB >> 9260873

Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme.

P A Deddish1, H L Jackman, R A Skidgel, E G Erdös.   

Abstract

The hydrolysis of enkephalin (Enk) congeners by the isolated N- (N-ACE) and C-domain of angiotensin I converting enzyme (ACE) and by the two-domain somatic ACE was investigated. Both Leu5- and Met5-Enk were cleaved faster by the C-domain than by N-ACE; rates with somatic ACE were 1600 and 2500 nmol/min/nmol enzyme with both active sites being involved. Substitution of Gly2 by D-Ala2 reduced the rate to 1/3rd to 1/7th of that of the Enks. N-ACE cleaved Met5-Enk-Arg6-Phe7 faster than the C-domain, probably with the highest turnover number of any naturally occurring ACE substrate (7600 min(-1)). This heptapeptide is also hydrolyzed in the absence of Cl-, but the activation by Cl- is unique; Cl- enhances the hydrolysis of the heptapeptide by N-ACE but inhibits it by the C-domain, yielding about a 5-fold difference in the turnover number at physiological pH. This difference may result in the predominant role of the N-domain in converting Met5-Enk-Arg6-Phe7 to Enk in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260873     DOI: 10.1016/s0006-2952(97)00087-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.

Authors:  Zhenlong Chen; Peter A Deddish; Richard D Minshall; Robert P Becker; Ervin G Erdös; Fulong Tan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

Review 3.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

4.  Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.

Authors:  Mohd Akif; Sylva L Schwager; Colin S Anthony; Bertrand Czarny; Fabrice Beau; Vincent Dive; Edward D Sturrock; K Ravi Acharya
Journal:  Biochem J       Date:  2011-05-15       Impact factor: 3.857

5.  Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Mohd Akif; Bertrand Czarny; Fabrice Beau; Sylva L U Schwager; Edward D Sturrock; R Elwyn Isaac; Vincent Dive; K Ravi Acharya
Journal:  FEBS J       Date:  2013-12-24       Impact factor: 5.542

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.